Braveheart Bio, Inc. (BRVE)

NASDAQ

$21.25

$-0.12

(-0.55%)

Pre-Market

Braveheart Bio, Inc. (BRVE) Live Price Chart

Last updated: ⁦2026-10-02 09:10:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Braveheart Bio, Inc. (BRVE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $21.25, with a market capitalization of $1.82B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19.88 to $32.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.82B
Open	$21.37
Day's High	$32.00
Day's Low	$19.88
Previous Close	$21.41
Volume	9.00
Average Volume	561.54K
P/E Ratio	--
52-Week High	$32.00
52-Week Low	$19.88
Dividend Yield	--
Earnings Date	--

Braveheart Bio, Inc. (BRVE) Pre-Market Stock Price

Braveheart Bio, Inc. (BRVE) is trading at $21.25 in pre-market trading as of 2026-10-02 08:26:00, down 0.74% ($0.16) from the previous close of $21.41

Pre-market trading shows how investors are pricing BRVE before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Braveheart Bio, Inc. (BRVE) 7-Day Stock Price Change

Over the past seven days, Braveheart Bio, Inc. (BRVE) moved from $21.46 to $21.25, representing a decline of 0.97% ($0.21).

The stock traded between $19.88 and $23.86 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 590.88 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BRVE 52-Week Price Position

Position in Range: 11.3%

52W Low$19.88

52W High$32.00

BRVE is currently trading at $21.25, placing it 11.3% of the way from its 52-week low of $19.88 to its 52-week high of $32.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Braveheart Bio, Inc. (BRVE)?

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

Braveheart Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.braveheart.bio

How to Buy Braveheart Bio, Inc. (BRVE) Stock on MEXC

Eligible investors can buy real shares of Braveheart Bio, Inc. (BRVE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BRVE and Place Your Order

Open the RealStocks trading page and search for BRVE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Braveheart Bio, Inc. (BRVE) stock price today?

Braveheart Bio, Inc. (BRVE) is currently trading at $ 21.25, down 0.74% ($0.16) from the previous close of $ 21.41. Intraday prices update in real time during regular trading hours.

2.Is BRVE stock going up or down today?

As of 2026-10-02 08:26:00, BRVE is trading at $ 21.25, down 0.74% ($0.16) from its previous close of $ 21.41. The stock has traded between $ 19.88 and $ 32.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is BRVE pre-market price?

As of 2026-10-02 08:26:00, BRVE is trading at $ 21.25 in pre-market trading, down 0.74% ($0.16) from the previous close of $ 21.41. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BRVE after-hours price?

As of 2026-10-02 08:26:00, BRVE is trading at $ 21.37 in after-hours trading, down 0.20% ($0.04) from the regular-session close of $ 21.41. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BRVE stock trading now?

BRVE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BRVE sit relative to its 52-week high and low?

Over the past 52 weeks, BRVE has traded between a low of $ 19.88 and a high of $ 32.00. At $ 21.25, the stock is positioned 11.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Braveheart Bio, Inc. in?

Braveheart Bio, Inc. (BRVE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Braveheart Bio, Inc.'s market capitalization and where is it listed?

Braveheart Bio, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.82B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BRVE valued in terms of P/E ratio and EPS?

BRVE trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Braveheart Bio, Inc. pay a dividend?

Braveheart Bio, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.